<?xml version="1.0" encoding="UTF-8"?>
<ref id="fcaa031-B50">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Jawaid</surname>
    <given-names>A</given-names>
   </name>, 
   <name name-style="western">
    <surname>Khan</surname>
    <given-names>R</given-names>
   </name>, 
   <name name-style="western">
    <surname>Polymenidou</surname>
    <given-names>M</given-names>
   </name>, 
   <name name-style="western">
    <surname>Schulz</surname>
    <given-names>PE.</given-names>
   </name>
  </person-group>
  <article-title>Disease-modifying effects of metabolic perturbations in ALS/FTLD</article-title>. 
  <source>Mol Neurodegener</source>
  <year>2018</year>; 
  <volume>13</volume>: 
  <fpage>63</fpage>.
  <pub-id pub-id-type="pmid">30509290</pub-id>
 </mixed-citation>
</ref>
